Syphilis Testing Market

Global Syphilis Testing Market Report: By Type (A Primary Syphilis and Secondary Syphilis), Application (Hospitals and Clinics), and Region (North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa) Global Industry Analysis, Size, Share, Growth, Trends, Regional Analysis, Competitor Analysis and Forecast 2024-2032.

Pharma & Healthcare | January 2024 | Report ID: EMR00474 | Pages: 301

Global Syphilis Testing Market is predicted to reach approximately USD 2.15 billion by 2032, at a CAGR of 6.31% from 2024 to 2032.

Treponema pallidum, the bacteria that causes syphilis, is a potentially dangerous STI that, if untreated, can have serious side effects. The market encompasses a wide range of testing methods, including traditional serological tests like rapid plasma reagin (RPR) and newer technologies such as nucleic acid amplification tests (NAATs). The need for precise and effective testing solutions is growing due to the increasing number of syphilis cases around the world and the ongoing efforts to stop it from spreading.

The syphilis testing market is characterized by a competitive landscape with key players continually investing in research and development to introduce innovative diagnostic tools. Governments and healthcare organizations worldwide are actively promoting screening programs to identify and treat syphilis cases early, fostering market growth. Additionally, advancements in technology have led to the development of point-of-care testing devices, enabling rapid and convenient diagnosis in various healthcare settings



Global Syphilis Testing report scope and segmentation.

Report Attribute


Estimated Market Value (2023)

USD 1.24 billion

Projected Market Value (2032)

USD 2.15 billion

Base Year


Forecast Years

2024 – 2032

Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Based on By Type, By Application, & Region.

Segments Covered

By Type, By Application, & By Region.

Forecast Units

Value (USD Billion or Million), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2023 to 2032.

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others.

Report Coverage

Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis.

Delivery Format

Delivered as an attached PDF and Excel through email, according to the purchase option.


Global Syphilis Testing dynamics

One of the main market drivers is the rising incidence of syphilis worldwide, which is being caused by altered sexual practices and low awareness. Proactive measures taken by governments and healthcare institutions to prevent the spread of STDs, such as syphilis, through awareness campaigns and screening initiatives, have a major positive impact on market expansion. The need for sophisticated and precise diagnostic solutions is growing, driving businesses to spend money on R&D and promoting technological advancements in testing approaches. Point-of-care testing devices have completely changed the game by allowing for quick and easy diagnosis in a variety of healthcare settings, which is further driving market expansion.

On the flip side, challenges such as stigma associated with STIs, particularly syphilis, may hinder testing uptake, leading to underreporting and inadequate screening. Moreover, economic disparities and variations in healthcare infrastructure across regions can impact the accessibility of testing services. Regulatory frameworks and reimbursement policies also play a crucial role in influencing market dynamics, shaping the competitive landscape and the adoption of novel testing solutions. The market is characterized by intense competition, with companies vying for market share through strategic collaborations, mergers, and acquisitions. As the healthcare industry continues to prioritize infectious disease control, the syphilis testing market dynamics are expected to evolve, guided by a complex interplay of technological advancements, regulatory considerations, and global public health initiatives.


Global Syphilis Testing drivers

  • Increasing Global Incidence of Syphilis  

The rising incidence of syphilis worldwide is a major factor propelling the market for syphilis testing. Changing sexual behaviours, a lack of awareness, and insufficient preventive measures are some of the factors contributing to the increasing prevalence of this sexually transmitted infection (STI). Worldwide syphilis cases are continuing to rise, and there is an increasing need for quick and accurate diagnostic procedures. This factor is driving the market forward by forcing governments and healthcare organisations to give screening programmes and awareness campaigns top priority.

  • Advancements in Diagnostic Technologies  

The continuous evolution of diagnostic technologies is a significant driver for the syphilis testing market. Ongoing research and development efforts have led to the introduction of innovative testing methods, including nucleic acid amplification tests (NAATs) and point-of-care testing devices. These advancements offer improved accuracy, sensitivity, and convenience in syphilis diagnosis, addressing the need for reliable testing solutions. The adoption of cutting-edge technologies enhances the overall efficiency of syphilis testing, contributing to the market's growth.



  • Stigma and Societal Barriers

Stigma associated with sexually transmitted infections, including syphilis, remains a notable restraint for the market. Societal taboos and discrimination against individuals with STIs can hinder testing uptake, leading to underreporting and a lack of comprehensive screening. Overcoming this barrier requires concerted efforts in public awareness campaigns to destigmatize STIs, emphasizing the importance of testing for early detection and treatment.

  • Economic Disparities and Limited Healthcare Infrastructure  

Disparities in healthcare infrastructure and economic status between areas make syphilis testing services difficult to access. Inadequate screening facilities and delayed diagnosis can be caused by resource limitations in some areas. To overcome this limitation, specific investments in healthcare infrastructure are needed, particularly in developing nations, to guarantee fair access to syphilis testing and improve overall disease management.



  • Rising Emphasis on Point-of-Care Testing  

The increasing emphasis on point-of-care testing presents a significant opportunity for the syphilis testing market. Point-of-care devices offer rapid and convenient diagnosis, enabling healthcare professionals to administer tests in diverse settings. The portability and quick results of these devices cater to the growing demand for on-the-spot diagnostics, especially in resource-limited environments and during outreach programs, opening up new avenues for market expansion.


Segment Overview

  • By Type

The syphilis testing market is segmented based on the stages of syphilis infection, categorizing cases into two primary types: Primary Syphilis and Secondary Syphilis.

Primary Syphilis: This segment encompasses cases in the initial stage of syphilis infection, where the primary lesion or sore, known as a chancre, develops at the site of infection. Primary syphilis is characterized by the presence of a painless sore and typically occurs within 10 to 90 days of exposure to the Treponema pallidum bacterium. Accurate and timely testing during this stage is crucial for early detection and intervention, preventing the progression of the infection to more advanced stages.

Secondary Syphilis: The secondary syphilis segment includes cases where the infection progresses beyond the initial stage, leading to a broader range of symptoms and potential complications. This stage is marked by skin rashes, mucous membrane lesions, and flu-like symptoms. Secondary syphilis can manifest weeks to months after the appearance of the primary chancre. Testing during this stage aids in confirming the diagnosis, guiding appropriate treatment, and mitigating the risk of severe complications associated with untreated syphilis.

  • By Application  

The syphilis testing market is further segmented based on the application, identifying key healthcare settings where testing is conducted: Hospitals and Clinics.

Hospitals: Hospitals play a pivotal role in syphilis testing, serving as comprehensive healthcare facilities equipped to handle various medical conditions. Syphilis testing in hospitals is often integrated into routine screening programs, emergency room visits, and prenatal care. The infrastructure and expertise available in hospitals enable the administration of diverse testing methodologies, contributing to the timely diagnosis and management of syphilis cases.

Clinics: Clinics, including specialized sexually transmitted infection clinics and primary care clinics, serve as accessible points for syphilis testing, particularly for individuals seeking targeted screening or concerned about potential exposure. Clinics often provide a more focused and personalized approach to testing, emphasizing confidentiality and patient education. This segment caters to individuals who may prefer a more discreet or specialized testing environment, contributing to the overall accessibility of syphilis testing services.


Global Syphilis Testing Overview by Region

At the moment, North America and Europe are leading the market due to their developed healthcare systems, effective awareness campaigns, and pro-active STI control policies. These regions benefit from a high prevalence of syphilis testing in both hospitals and clinics, along with the integration of advanced diagnostic technologies. But in order to sustain growth as these markets get closer to saturation, attention is turning to technological advancements and the creation of more affordable testing options.

In contrast, the Asia-Pacific region and Latin America present significant growth opportunities for the syphilis testing market. The rising incidence of syphilis, coupled with increasing healthcare investments and government initiatives to enhance STI screening programs, fuels market expansion. Economic development, coupled with growing awareness, is contributing to improved access to testing services in clinics and hospitals. The adoption of point-of-care testing devices is particularly promising in these regions, addressing the need for convenient and rapid diagnostic solutions.

In Africa, the syphilis testing market faces unique challenges, including limited healthcare infrastructure and resource constraints. However, the prevalence of syphilis remains a concern, necessitating concerted efforts to enhance testing accessibility and implement targeted screening programs. Collaborations between international health organizations and local governments are crucial in addressing these challenges, with an emphasis on capacity building and the development of sustainable testing solutions.



Global Syphilis Testing market competitive landscape

Key players such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers dominate the market with a diverse portfolio of syphilis testing products, including traditional serological tests and cutting-edge nucleic acid amplification tests (NAATs). These industry leaders focus on continuous research and development to introduce innovative technologies, enhancing the sensitivity and specificity of diagnostic tools. Strategic collaborations and partnerships are commonplace, enabling companies to expand their product offerings and strengthen their market presence.

The market also witnesses the emergence of niche players specializing in point-of-care testing devices. Companies like Cepheid and Chembio Diagnostics focus on providing rapid and convenient syphilis testing solutions suitable for various healthcare settings. The emphasis on portable and easy-to-use devices aligns with the global trend towards decentralized testing, catering to the need for on-the-spot diagnosis, particularly in resource-limited environments.

Furthermore, the competitive landscape is influenced by regional players that cater to specific geographic markets. Local manufacturers in Asia-Pacific, Latin America, and Africa contribute to market diversity by addressing regional preferences and healthcare needs. These companies often play a vital role in enhancing testing accessibility and affordability in their respective regions.


Global Syphilis Testing Recent Developments

  • Feb 2023, Caraway and Ash Wellness have joined forces to address the increasing prevalence of sexually transmitted infections (STIs) on college campuses. As part of this collaboration, Caraway members now have the option to request an STI Kit designed for Gen Z, conveniently delivered to their doorstep. These kits encompass a range of tests for STIs and sexual health, covering chlamydia, gonorrhea, syphilis, HIV, hepatitis C, trichomoniasis, candidiasis, and bacterial vaginosis.
  • Nov 2021, MedAccess, the Clinton Health Access Initiative (CHAI), and SD Biosensor have joined forces to enhance the availability of an innovative dual rapid testing solution for syphilis and HIV. The STANDARD Q HIV/Syphilis Combo test by SD Biosensor has earned the distinction of being the initial World Health Organization (WHO) prequalified combination HIV/syphilis test accessible for less than $1, specifically catering to public sector buyers in low- and middle-income nations.  


Scope of global Syphilis Testing report

Global Syphilis Testing report segmentation



By Type  

  • Primary Syphilis
  • Secondary Syphilis

By Application

  • Hospitals
  • Clinics

By Geography

  • North America (USA, and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Customization Scope

  • Available upon request


  • Available upon request


Objectives of the Study

The objectives of the study are summarized in 5 stages. They are as mentioned below:

  • Global Syphilis Testing size and forecast: To identify and estimate the market size for global Syphilis Testing market segmented by Type, By Application, and by region. Also, to understand the consumption/ demand created by consumers between 2024 and 2032.
  • Market Landscape and Trends: To identify and infer the drivers, restraints, opportunities, and challenges for global Syphilis Testing
  • Market Influencing Factors: To find out the factors which are affecting the market of global Syphilis Testing among consumers.
  • Company Profiling:  To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company's past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

Research Methodology

Our research methodology has always been the key differentiating reason which sets us apart in comparison from the competing organizations in the industry. Our organization believes in consistency along with quality and establishing a new level with every new report we generate; our methods are acclaimed and the data/information inside the report is coveted. Our research methodology involves a combination of primary and secondary research methods. Data procurement is one of the most extensive stages in our research process. Our organization helps in assisting the clients to find the opportunities by examining the market across the globe coupled with providing economic statistics for each and every region.  The reports generated and published are based on primary & secondary research. In secondary research, we gather data for global Market through white papers, case studies, blogs, reference customers, news, articles, press releases, white papers, and research studies. We also have our paid data applications which includes hoovers, Bloomberg business week, Avention, and others.

Data Collection

Data collection is the process of gathering, measuring, and analyzing accurate and relevant data from a variety of sources to analyze market and forecast trends. Raw market data is obtained on a broad front. Data is continuously extracted and filtered to ensure only validated and authenticated sources are considered. Data is mined from a varied host of sources including secondary and primary sources.

Primary Research

After the secondary research process, we initiate the primary research phase in which we interact with companies operating within the market space. We interact with related industries to understand the factors that can drive or hamper a market. Exhaustive primary interviews are conducted. Various sources from both the supply and demand sides are interviewed to obtain qualitative and quantitative information for a report which includes suppliers, product providers, domain experts, CEOs, vice presidents, marketing & sales directors, Type & innovation directors, and related key executives from various key companies to ensure a holistic and unbiased picture of the market. 

Secondary Research

A secondary research process is conducted to identify and collect information useful for the extensive, technical, market-oriented, and comprehensive study of the market. Secondary sources include published market studies, competitive information, white papers, analyst reports, government agencies, industry and trade associations, media sources, chambers of commerce, newsletters, trade publications, magazines, Bloomberg BusinessWeek, Factiva, D&B, annual reports, company house documents, investor presentations, articles, journals, blogs, and SEC filings of companies, newspapers, and so on. We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

Top-Down Approach & Bottom-Up Approach

In the top – down approach, the Global Batteries for Solar Energy Storage Market was further divided into various segments on the basis of the percentage share of each segment. This approach helped in arriving at the market size of each segment globally. The segments market size was further broken down in the regional market size of each segment and sub-segments. The sub-segments were further broken down to country level market. The market size arrived using this approach was then crosschecked with the market size arrived by using bottom-up approach.

In the bottom-up approach, we arrived at the country market size by identifying the revenues and market shares of the key market players. The country market sizes then were added up to arrive at regional market size of the decorated apparel, which eventually added up to arrive at global market size.

This is one of the most reliable methods as the information is directly obtained from the key players in the market and is based on the primary interviews from the key opinion leaders associated with the firms considered in the research. Furthermore, the data obtained from the company sources and the primary respondents was validated through secondary sources including government publications and Bloomberg.

Market Analysis & size Estimation

Post the data mining stage, we gather our findings and analyze them, filtering out relevant insights. These are evaluated across research teams and industry experts. All this data is collected and evaluated by our analysts. The key players in the industry or markets are identified through extensive primary and secondary research. All percentage share splits, and breakdowns have been determined using secondary sources and verified through primary sources. The market size, in terms of value and volume, is determined through primary and secondary research processes, and forecasting models including the time series model, econometric model, judgmental forecasting model, the Delphi method, among Flywheel Energy Storage. Gathered information for market analysis, competitive landscape, growth trends, product development, and pricing trends is fed into the model and analyzed simultaneously.

Quality Checking & Final Review

The analysis done by the research team is further reviewed to check for the accuracy of the data provided to ensure the clients’ requirements. This approach provides essential checks and balances which facilitate the production of quality data. This Type of revision was done in two phases for the authenticity of the data and negligible errors in the report. After quality checking, the report is reviewed to look after the presentation, Type and to recheck if all the requirements of the clients were addressed.

Frequently Asked Questions

Global Syphilis Testing forecast period is 2024 - 2032.
According to global Syphilis Testing research, the market is expected to grow at a CAGR of ~ 6.31% over the next eight years.
The possible segments in global Syphilis Testing are based on by Type, By Application, & by region.
The expected market size for Global Syphilis Testing is USD 1.24 billion in 2023.
The major players in the market are Beckman Coulter Inc., Bio Rad Laboratories Inc., Becton Dickinson and Co., bioLytical Laboratories Inc., Bloodworks Northwest, Calibre Scientific Inc., Danaher Corp., DiaSorin SpA, Everlywell Inc., and F. Hoffmann La Roche Ltd.

Avail PDF Sample Reports